|
1
|
Frostegard J: Immunity, atherosclerosis
and cardiovascular disease. BMC Med. 11:1172013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh R, Devi S and Gollen R: Role of free
radical in atherosclerosis, diabetes and dyslipidaemia:
Larger-than-life. Diabetes Metab Res Rev. 31:113–126. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meijles DN and Pagano PJ: Nox and
inflammation in the vascular adventitia. Hypertension. 67:14–19.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujii S: Atherosclerosis, chronic
inflammation, and thrombosis: In search of the missing link in
laboratory medicine. Rinsho Byori. 63:605–611. 2015.(In Japanese).
PubMed/NCBI
|
|
5
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol
(Oxf). 214:33–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang X, Shao S, Geng H, Yu Y, Wang C, Liu
Z, Yu C, Jiang X, Deng Y, Gao L and Zhao J: Expression profiles of
six circulating microRNAs critical to atherosclerosis in patients
with subclinical hypothyroidism: A clinical study. J Clin
Endocrinol Metab. 99:E766–E774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hasanov Z, Ruckdeschel T, Konig C, Mogler
C, Kapel SS, Korn C, Spegg C, Eichwald V, Wieland M, Appak S and
Augustin HG: Endosialin promotes atherosclerosis through phenotypic
remodeling of vascular smooth muscle cells. Arterioscler Thromb
Vasc Biol. 37:495–505. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Byon CH, Han T, Wu J and Hui ST: Txnip
ablation reduces vascular smooth muscle cell inflammation and
ameliorates atherosclerosis in apolipoprotein E knockout mice.
Atherosclerosis. 241:313–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duarte FV, Palmeira CM and Rolo AP: The
emerging role of mitomiRs in the pathophysiology of human disease.
Adv Exp Med Biol. 888:123–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Donaldson CJ, Lao KH and Zeng L: The
salient role of microRNAs in atherogenesis. J Mol Cell Cardiol.
122:98–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lucas T, Bonauer A and Dimmeler S: RNA
therapeutics in cardiovascular disease. Circ Res. 123:205–220.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Li W, Zhang Y and Yang J:
MicroRNA-20a protects human aortic endothelial cells from
Ox-LDL-induced inflammation through targeting TLR4 and TXNIP
signaling. Biomed Pharmacother. 103:191–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hao L, Wang XG, Cheng JD, You SZ, Ma SH,
Zhong X, Quan L and Luo B: The up-regulation of endothelin-1 and
down-regulation of miRNA-125a-5p, −155, and −199a/b-3p in human
atherosclerotic coronary artery. Cardiovasc Pathol. 23:217–223.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He Y, Hara H and Nunez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sutterwala FS, Haasken S and Cassel SL:
Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci.
1319:82–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di X, Tang X and Di X: Montelukast
inhibits oxidized low-density lipoproteins (ox-LDL) induced
vascular endothelial attachment: An implication for the treatment
of atherosclerosis. Biochem Biophys Res Commun. 486:58–62. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karim MR, Rahman M, Islam K, Mamun AA,
Hossain S, Hossain E, Aziz A, Yeasmin F, Agarwal S, Hossain MI, et
al: Increases in oxidized low-density lipoprotein and other
inflammatory and adhesion molecules with a concomitant decrease in
high-density lipoprotein in the individuals exposed to arsenic in
Bangladesh. Toxicol Sci. 135:17–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li WL, Hua LG, Qu P, Yan WH, Ming C, Jun
YD, Yuan LD and Nan N: NLRP3 inflammasome: A novel link between
lipoproteins and atherosclerosis. Arch Med Sci. 12:950–958. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Warnatsch A, Ioannou M, Wang Q and
Papayannopoulos V: Inflammation. Neutrophil extracellular traps
license macrophages for cytokine production in atherosclerosis.
Science. 349:316–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eun SY, Ko YS, Park SW, Chang KC and Kim
HJ: IL-1β enhances vascular smooth muscle cell proliferation and
migration via P2Y2 receptor-mediated RAGE expression and HMGB1
release. Vascul Pharmacol. 72:108–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aday AW and Ridker PM: Antiinflammatory
therapy in clinical care: The CANTOS trial and beyond. Front
Cardiovasc Med. 5:622018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao
MX, Wang JJ, Zhou YB, Han Y, Chen Q, Li YH, et al: NLRP3
inflammasome activation contributes to VSMC phenotypic
transformation and proliferation in hypertension. Cell Death Dis.
8:e30742017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ,
Qiu JH and Liu Q: Role of the NLRP3 inflammasome in the transient
release of IL-1beta induced by monosodium urate crystals in human
fibroblast-like synoviocytes. J Inflamm (Lord). 12:302015.
View Article : Google Scholar
|
|
26
|
Yamaguchi Y, Kurita-Ochiai T, Kobayashi R,
Suzuki T and Ando T: Activation of the NLRP3 inflammasome in
Porphyromonas gingivalis-accelerated atherosclerosis. Pathog Dis.
73:ftv0112015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Natalia MA, Alejandro GT, Virginia TJ and
Alvarez-Salas LM: MARK1 is a novel target for miR-125a-5p:
Implications for cell migration in cervical tumor cells. Microma.
7:54–61. 2018.
|
|
28
|
Verite J, Janet T, Julian A, Chassaing D,
Page G and Paccalin M: Peripheral blood mononuclear cells of
Alzheimer's disease patients control CCL4 and CXCL10 levels in a
human blood brain barrier model. Curr Alzheimer Res. 14:1215–1228.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edsfeldt A, Grufman H, Asciutto G,
Nitulescu M, Persson A, Nilsson M, Nilsson J and Gonçalves:
Circulating cytokines reflect the expression of pro-inflammatory
cytokines in atherosclerotic plaques. Atherosclerosis. 241:443–449.
2015. View Article : Google Scholar : PubMed/NCBI
|
